News & Events


The Milbank Quarterly
Improving Food and Drug Administration–Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated Approval
The New England Journal of Medicine
Turning CMS into a health technology assessment organization
JAMA Network Open
Follow-On Indications for Orphan Drugs Related to the Inflation Reduction Act
Journal of Market Access & Health Policy
Rule of Prevention: a potential framework to evaluate preventive interventions for rare diseases
Health Affairs Scholar
Commercial Coverage of Specialty Drugs 2017-2021
Health Affairs Forefront
Medicare And Alzheimer’s Drug Coverage: Balancing Evidence Generation And Patient Access
Journal of Managed Care and Specialty Pharmacy
Specialty drug coverage varies between health plans’ medical and pharmacy benefit policies
International Journal of Tech Assessment in Health Care
A Review of HTA Guidelines on Societal and Novel Value Elements
Journal of the American Medical Association
Cost-effectiveness thresholds used by study authors, 1990-2021